These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 3835769)
1. [Evaluation of the stability of lyophilized factor IX concentrate]. Hoffmann S; Bykowska K; Lukasiak S; Lopaciuk S Acta Haematol Pol; 1985; 16(3-4):135-8. PubMed ID: 3835769 [No Abstract] [Full Text] [Related]
2. In vitro stability studies of a Factor IX concentrate (Bebulin). Dal Bo Zanon R; Gazzetta R; Patrassi G; Stocco D; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):874-8. PubMed ID: 6200399 [TBL] [Abstract][Full Text] [Related]
3. [Concentrate of coagulation factor IX: viral validation of the thermoinactivation process]. Zahorska R; Buchowicz I; Ejduk A Acta Haematol Pol; 1995; 26(4):421-4. PubMed ID: 8571744 [TBL] [Abstract][Full Text] [Related]
4. The stability of factor IX concentrate during storage. Suomela H; Vahtera E Thromb Haemost; 1982 Apr; 47(2):114-5. PubMed ID: 7101229 [TBL] [Abstract][Full Text] [Related]
5. Comparison of two stability programs for lyophilized coenzyme B12 in ampoules. Colombo BM; Causa P; Primavera P Arzneimittelforschung; 1971 Jan; 21(1):93-5. PubMed ID: 5108206 [No Abstract] [Full Text] [Related]
6. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11). Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002 [TBL] [Abstract][Full Text] [Related]
7. The formulation of recombinant factor IX: stability, robustness, and convenience. Bush L; Webb C; Bartlett L; Burnett B Semin Hematol; 1998 Apr; 35(2 Suppl 2):18-21. PubMed ID: 9565162 [TBL] [Abstract][Full Text] [Related]
8. [Heat stability of a lyophilized inactivated anti-rabies-vaccine]. Jaeger O; Barth R Zentralbl Bakteriol Orig; 1969 May; 210(1):135-9. PubMed ID: 5361074 [No Abstract] [Full Text] [Related]
9. [For better stability of lyophilized drugs. Recent technological development in pre-freezing]. Rigoli A Boll Chim Farm; 1974 Sep; 113(9):461-6. PubMed ID: 4447684 [No Abstract] [Full Text] [Related]
10. [The way to long-term ambient temperature stabilization of biologicals--freeze-drying and evaporative-drying with vitrification]. Franks F; Terashima M Tanpakushitsu Kakusan Koso; 1996 May; 41(6):810-6. PubMed ID: 8787051 [No Abstract] [Full Text] [Related]
11. [Stability of lyophilized smallpox vaccine after more than 3 years of storage in temperatures of the environment]. Kühn O Z Gesamte Hyg; 1967 Jul; 13(7):487-93. PubMed ID: 5594126 [No Abstract] [Full Text] [Related]
12. Comparison of amino acid stabilities in casein hydrolysate solution and in lyophilized casein hydrolysate samples under various storage conditions. Friend JE; Stegink LD; Kann DE Am J Hosp Pharm; 1972 Oct; 29(10):835-9. PubMed ID: 5075123 [No Abstract] [Full Text] [Related]
13. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients. Anhorn MG; Mahler HC; Langer K Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043 [TBL] [Abstract][Full Text] [Related]
14. The stability of the Romanian freeze-dried BCG vaccine. Balazs D; Piţur I; Drăghici D Arch Roum Pathol Exp Microbiol; 1982; 41(2):141-6. PubMed ID: 7149960 [No Abstract] [Full Text] [Related]
18. An evaluation of the stability of Brucella abortus strain 19 reduced dosage lyophilized vaccines produced by different methods. Angus RD Dev Biol Stand; 1984; 56():659-78. PubMed ID: 6436119 [TBL] [Abstract][Full Text] [Related]
19. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications]. Allain JP Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617 [No Abstract] [Full Text] [Related]